PL3996699T3 - Kombinacja ibuprofenu i tramadolu do uśmierzania bólu - Google Patents

Kombinacja ibuprofenu i tramadolu do uśmierzania bólu

Info

Publication number
PL3996699T3
PL3996699T3 PL20740266.0T PL20740266T PL3996699T3 PL 3996699 T3 PL3996699 T3 PL 3996699T3 PL 20740266 T PL20740266 T PL 20740266T PL 3996699 T3 PL3996699 T3 PL 3996699T3
Authority
PL
Poland
Prior art keywords
tramadol
ibuprofen
combination
relieving pain
relieving
Prior art date
Application number
PL20740266.0T
Other languages
English (en)
Inventor
Antonio PORTOLÉS PÉREZ
Luis Narciso SANTÉ SERNA
María del Rosario SALAS BUTRÓN
Emilio VARGAS CASTRILLÓN
Carlos CALANDRIA PÉREZ
Raquel HORCAJADA CÓRDOBA
Ángel José MUÑOZ RUIZ
Marta Vicario De La Torre
Nuria SANZ MENÉNDEZ
Antonia GÓMEZ CALVO
Jose Angel SÁNCHEZ GARCÍA
Ester DUART GONZALEZ
Fernando García Alonso
Original Assignee
Farmalider, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider, S.A. filed Critical Farmalider, S.A.
Publication of PL3996699T3 publication Critical patent/PL3996699T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL20740266.0T 2019-07-09 2020-07-08 Kombinacja ibuprofenu i tramadolu do uśmierzania bólu PL3996699T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382583 2019-07-09
PCT/EP2020/069306 WO2021005129A1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Publications (1)

Publication Number Publication Date
PL3996699T3 true PL3996699T3 (pl) 2023-10-30

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20740266.0T PL3996699T3 (pl) 2019-07-09 2020-07-08 Kombinacja ibuprofenu i tramadolu do uśmierzania bólu

Country Status (20)

Country Link
US (1) US20220249414A1 (pl)
EP (1) EP3996699B1 (pl)
JP (1) JP2022540854A (pl)
CN (1) CN114080221B (pl)
AU (1) AU2020309160A1 (pl)
BR (1) BR112022000242A2 (pl)
CA (1) CA3145632C (pl)
DK (1) DK3996699T3 (pl)
ES (1) ES2952013T3 (pl)
FI (1) FI3996699T3 (pl)
HR (1) HRP20230677T1 (pl)
HU (1) HUE062529T2 (pl)
MA (1) MA56341B1 (pl)
MD (1) MD3996699T2 (pl)
MX (1) MX2022000373A (pl)
PL (1) PL3996699T3 (pl)
PT (1) PT3996699T (pl)
RS (1) RS64500B1 (pl)
SI (1) SI3996699T1 (pl)
WO (1) WO2021005129A1 (pl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
ES2356762B1 (es) 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
ES2423866B1 (es) 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico

Also Published As

Publication number Publication date
AU2020309160A1 (en) 2022-02-17
MA56341B1 (fr) 2023-07-31
CA3145632A1 (en) 2021-01-14
SI3996699T1 (sl) 2023-10-30
FI3996699T3 (fi) 2023-08-01
ES2952013T3 (es) 2023-10-26
HUE062529T2 (hu) 2023-11-28
PT3996699T (pt) 2023-07-27
MD3996699T2 (ro) 2023-11-30
US20220249414A1 (en) 2022-08-11
JP2022540854A (ja) 2022-09-20
EP3996699A1 (en) 2022-05-18
RS64500B1 (sr) 2023-09-29
MX2022000373A (es) 2022-02-10
EP3996699B1 (en) 2023-06-28
CN114080221A (zh) 2022-02-22
WO2021005129A1 (en) 2021-01-14
BR112022000242A2 (pt) 2022-05-31
CN114080221B (zh) 2023-12-05
DK3996699T3 (da) 2023-07-24
CA3145632C (en) 2024-03-12
HRP20230677T1 (hr) 2023-10-13

Similar Documents

Publication Publication Date Title
IL277234A (en) Systems and methods for treating hemoglobin diseases
IL292810A (en) Therapeutic compounds and methods of use
IL291217A (en) usp30 inhibitors and their uses
IL272036A (en) Methods and compositions for treating pain using capsaicin
IL282095A (en) Systems and methods for increasing the effectiveness of ultrasound therapy
IL286079A (en) History of imidazolonylquiniline and their medical uses
EP4058037A4 (en) FIBROBLAST THERAPY FOR THE TREATMENT AND PREVENTION OF STROKE
EP3962428A4 (en) THERAPEUTIC COMPRESSION SYSTEM AND METHODS OF USE
ZA202207188B (en) Liquid tasimelteon formulations and methods of use thereof
IL284029B1 (en) Peptides for the treatment and prevention of diabetes and related disorders
EP4056683A4 (en) CEREBRAL ORGANOID AND CORRESPONDING USE
EP3818981C0 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION OF THE ACTIVE ENANTIOMER (S)-KETOROLAC AND GABAPENTIN FOR THE TREATMENT OF NEUROPATHIC PAIN
EP3777849A4 (en) PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR THE TREATMENT OF PAIN
HUE062529T2 (hu) Ibuprofén és tramadol kombinációja fájdalom csillapítására
IL287955A (en) Use of tramadol and celecoxib co-crystals to treat pain while reducing the potential for tramadol abuse
GB2600270B (en) Polymer-comrprising medical devices and uses thereof
IL284689A (en) Endoscopic device and methods of its use
EP4031667C0 (en) CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
IL276228A (en) Compounds and preparations for the treatment of pain
GB201918541D0 (en) Therapeutic compounds and their use
GB201918879D0 (en) Treatment of chronic pain
GB201913312D0 (en) Treatment of hypothyroidism and related conditions
EP3914147A4 (en) DEVICES AND METHODS FOR DIAGNOSIS AND TREATMENT OF DISCOGENIC BACK PAIN
ZA201904326B (en) Treatment of joint pain
GB2574944B (en) Methods and compositions for the treatment of pain and/or inflammation